Fennec Pharmaceuticals Inc. (FENC)
CIK 1211583 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Fennec Pharmaceuticals Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 2, 2026 | 4 | 0001468308-26-000036 |
| Nov 2, 2026 | 4 | 0002043411-26-000020 |
| Nov 2, 2026 | 4 | 0002043317-26-000018 |
| Nov 2, 2026 | 4 | 0002043395-26-000018 |
| Nov 2, 2026 | 4 | 0001926254-26-000020 |
| Oct 19, 2026 | SCHEDULE 13G/A | 0001493152-26-047509 |
| Oct 13, 2026 | 4 | 0002043395-26-000016 |
| Oct 13, 2026 | 4 | 0002043317-26-000016 |
| Oct 13, 2026 | 4 | 0001468308-26-000034 |
| Oct 13, 2026 | 4 | 0002043411-26-000018 |
| Oct 13, 2026 | 4 | 0001926254-26-000018 |
| Oct 1, 2026 | 4 | 0001926254-26-000016 |
| Oct 1, 2026 | 4 | 0002043411-26-000016 |
| Oct 1, 2026 | 4 | 0002043317-26-000014 |
| Oct 1, 2026 | 4 | 0001468308-26-000032 |
| Oct 1, 2026 | 4 | 0002043395-26-000014 |
| Sep 17, 2026 | 8-K | 0001104659-26-108565 |
| Sep 16, 2026 | 4 | 0001589776-26-000004 |
| Sep 15, 2026 | 144 | 0001950047-26-009471 |
| Sep 1, 2026 | 4 | 0001468316-26-000023 |
| Sep 1, 2026 | 144 | 0001950047-26-008901 |
| Aug 31, 2026 | 4 | 0002043317-26-000012 |
| Aug 31, 2026 | 4 | 0002043395-26-000012 |
| Aug 31, 2026 | 144 | 0001950047-26-008849 |
| Aug 31, 2026 | 4 | 0001926254-26-000014 |